| Sep 12 |
PBM executives decline to revise controversial testimony to House committee
|
| Sep 11 |
Major PBMs could be zeroing in on specific payer markets for dominance, study suggests
|
| Sep 10 |
UnitedHealth joins Cigna, CVS in removing AbbVie's Humira from formularies: report
|
| Sep 10 |
Cigna Stock Gains 26% in a Year: What Lies Ahead for Investors?
|
| Sep 9 |
Beyond The Numbers: 8 Analysts Discuss Cigna Stock
|
| Sep 9 |
CVS, Humana dip amid new mental health guidelines, Leerink note
|
| Sep 9 |
The Cigna Group's "Community Vitality Project" Donates $75,000 to Nonprofits through Program Encouraging Fitness and Community Engagement
|
| Sep 5 |
The Cigna Group (CI) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript)
|
| Sep 5 |
Cigna to offer biosimilar to J&J’s arthritis drug Stelara at $0 out-of-pocket
|
| Sep 5 |
Evernorth announces another step forward in lowering drug prices by making a Stelara biosimilar available at $0 out of pocket for patients early next year
|
